Adam Sieg
YOU?
Author Swipe
View article: Evaluation of adjusted international normalized ratio goal in patients with <scp>HeartMate</scp> 3 left ventricular assist devices
Evaluation of adjusted international normalized ratio goal in patients with <span>HeartMate</span> 3 left ventricular assist devices Open
Background The HeartMate3 left ventricular assist device (HM3 LVAD) has shown a low incidence of thrombosis, but bleeding risk is as high as 43%. We aim to describe the impact of lower international normalization ratio (INR) goal on clinic…
View article: Overview of Pharmacological Considerations in Extracorporeal Membrane Oxygenation
Overview of Pharmacological Considerations in Extracorporeal Membrane Oxygenation Open
Extracorporeal membrane oxygenation has become more widely used in recent years. Although this technology has proven to be lifesaving, it is not devoid of complications contributing to significant morbidity and mortality. Nurses who care f…
View article: Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices
Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices Open
Background: Left ventricular assist device (LVAD) therapy has been proven to relieve heart failure symptoms and improve survival, but is not devoid of bleeding and/or thrombotic complications. Risk stratification tools have been utilized i…
View article: Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients
Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients Open
The use of left ventricular assist devices (LVAD) provides a treatment strategy for advanced heart failure patients to prolong life and serve as a mediator (bridge to transplant) until an organ becomes available in patients considered suit…
View article: Bivalirudin Medication Use Evaluation and Cost Savings Initiative
Bivalirudin Medication Use Evaluation and Cost Savings Initiative Open
Bivalirudin is a parenteral anticoagulant that elicits its effect through inhibition of both free and clot bound-thrombin. Inhibition of thrombin serves as a unique mechanism for anticoagulation when compared to heparin as thrombin serves …
View article: Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients
Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients Open
The use of left ventricular assist devices (LVAD) provides a treatment strategy for advanced heart failure patients to prolong life and serve as a mediator (bridge to transplant) until an organ becomes available in patients considered suit…
View article: Evaluation of Dosing Practices of Rivaroxaban and Dabigatran
Evaluation of Dosing Practices of Rivaroxaban and Dabigatran Open
Background: Anticoagulation is standard practice for the prevention and treatment of thromboembolic events. Two of the newer agents, rivaroxaban (Xarelto) and dabigatran (Pradaxa) are being utilized frequently in the inpatient and outpatie…